Clinical Trial Update: Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluation of Glizigen and Ocoxin-Viusid for high-grade cervical intraepithelial lesions is ongoing with an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma
• Cervical Intraepithelial Neoplasia
• Epithelial Neoplasm
• Glandular Neoplasms
• Neoplasms

Drugs mentioned

• Glizigen (null)
• Ocoxin®-Viusid®

Snippet

Sponsor: Catalysis SL | Conditions: Carcinoma, Neoplasia; Intraepithelial, Cervix | Phase 2 | Status: UNKNOWN